Subject: Oncolytic Virus Kills Tumor Cells and Supports Immune Cells - Cancer Currents Blog
From: National Cancer Institute <[email-masked]>
To: [email-masked]
Date: Wed, 16 Oct 2019 14:32:29 +0000

Having trouble viewing this email? View it as a Web page.

You are subscribed to Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Recent posts are listed below.

Dual-Function Virus Engineered to Kill Tumor Cells and Support Immune Cells

10/15/2019

Researchers have engineered an oncolytic virus to kill cancer cells and boost the immune response against tumors. In a new study, the virus provided T cells around tumors with a hormone they need for their own cell-killing functions.

Stay Connected with the National Cancer Institute

Chat with us: LiveHelp       Call us: 1-800-4-CANCER (1-800-422-6237)

SUBSCRIBER SERVICES:
Manage Subscriptions  |  Help

This email was sent to [email-masked] using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892